Weaver C. Barksdale & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.32M | Sell |
5,202
-10
| -0.2% | -$2.33K | 1.19% | 52 |
|
|
2026
Q1 | $1.27M | Sell |
5,212
-171
| -3% | -$39.8K | 1.21% | 50 |
|
|
2025
Q4 | $1.12M | Sell |
5,383
-1,052
| -16% | -$208K | 1.17% | 48 |
|
|
2025
Q3 | $1.19M | Sell |
6,435
-606
| -9% | -$104K | 1.15% | 47 |
|
|
2025
Q2 | $1.08M | Sell |
7,041
-87
| -1% | -$13.4K | 1.03% | 54 |
|
|
2025
Q1 | $1.18M | Sell |
7,128
-240
| -3% | -$37.6K | 1.13% | 53 |
|
|
2024
Q4 | $1.07M | Sell |
7,368
-260
| -3% | -$40.3K | 1.02% | 56 |
|
|
2024
Q3 | $1.24M | Sell |
7,628
-405
| -5% | -$64.5K | 1.11% | 52 |
|
|
2024
Q2 | $1.17M | Sell |
8,033
-186
| -2% | -$27.7K | 1.11% | 50 |
|
|
2024
Q1 | $1.3M | Sell |
8,219
-87
| -1% | -$13.8K | 1.19% | 51 |
|
|
2023
Q4 | $1.3M | Sell |
8,306
-2,285
| -22% | -$350K | 1.27% | 48 |
|
|
2023
Q3 | $1.65M | Buy |
10,591
+555
| +6% | +$91.6K | 1.41% | 44 |
|
|
2023
Q2 | $1.66M | Sell |
10,036
-740
| -7% | -$119K | 1.64% | 40 |
|
|
2023
Q1 | $1.67M | Buy |
10,776
+1,596
| +17% | +$258K | 1.56% | 40 |
|
|
2022
Q4 | $1.62M | Buy |
9,180
+259
| +3% | +$44.7K | 1.43% | 46 |
|
|
2022
Q3 | $1.46M | Sell |
8,921
-353
| -4% | -$59.7K | 1.46% | 44 |
|
|
2022
Q2 | $1.65M | Buy |
9,274
+85
| +0.9% | +$15.1K | 1.53% | 41 |
|
|
2022
Q1 | $1.63M | Buy |
9,189
+128
| +1% | +$21.8K | 1.45% | 45 |
|
|
2021
Q4 | $1.55M | Buy |
+9,061
| New | +$1.48M | 1.4% | 50 |
|
|
2017
Q4 | $1.59M | Sell |
11,405
-153
| -1% | -$21.3K | 1.68% | 22 |
|
|
2017
Q3 | $1.5M | Hold |
11,558
| – | – | 1.68% | 20 |
|
|
2017
Q2 | $1.53M | Hold |
11,558
| – | – | 1.78% | 9 |
|
|
2017
Q1 | $1.44M | Buy |
11,558
+2,709
| +31% | +$324K | 1.7% | 17 |
|
|
2016
Q4 | $1.02M | Sell |
8,849
-50
| -0.6% | -$5.78K | 1.64% | 12 |
|
|
2016
Q3 | $1.05M | Buy |
8,899
+199
| +2% | +$24.1K | 1.77% | 3 |
|
|
2016
Q2 | $1.05M | Hold |
8,700
| – | – | 1.83% | 8 |
|
|
2016
Q1 | $941K | Sell |
8,700
-58
| -0.7% | -$6K | 0.71% | 42 |
|
|
2015
Q4 | $900K | Hold |
8,758
| – | – | 0.7% | 41 |
|
|
2015
Q3 | $818K | Hold |
8,758
| – | – | 0.66% | 46 |
|
|
2015
Q2 | $854K | Buy |
8,758
+1,013
| +13% | +$101K | 0.63% | 49 |
|
|
2015
Q1 | $779K | Hold |
7,745
| – | – | 0.59% | 63 |
|
|
2014
Q4 | $810K | Sell |
7,745
-131
| -2% | -$13.8K | 0.65% | 57 |
|
|
2014
Q3 | $840K | Hold |
7,876
| – | – | 0.69% | 38 |
|
|
2014
Q2 | $824K | Hold |
7,876
| – | – | 0.66% | 43 |
|
|
2014
Q1 | $774K | Hold |
7,876
| – | – | 0.65% | 47 |
|
|
2013
Q4 | $721K | Buy |
7,876
+30
| +0.4% | +$2.77K | 0.61% | 56 |
|
|
2013
Q3 | $680K | Buy |
7,846
+3,885
| +98% | +$349K | 0.62% | 44 |
|
|
2013
Q2 | $340K | Buy |
+3,961
| New | +$336K | 0.33% | 68 |
|
Other funds holding JNJ
Weaver C. Barksdale & Associates's JNJ Position: Q2 2026 in Review
Weaver C. Barksdale & Associates reduced its Johnson & Johnson (JNJ) stake by 0.19% in Q2 2026, selling an estimated $2.33K and leaving 5,202 shares worth $1.32M. The position accounts for 1.19% of the portfolio, ranked #52.
Weaver C. Barksdale & Associates first reported a position in JNJ in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.67M in Q1 2023. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Weaver C. Barksdale & Associates held 5,202 shares of Johnson & Johnson worth $1.32M as of Q2 2026.
- Weaver C. Barksdale & Associates sold 10 Johnson & Johnson shares in Q2 2026, an estimated $2.33K.
- Johnson & Johnson made up 1.19% of Weaver C. Barksdale & Associates's portfolio in Q2 2026, its #52 holding.
- Weaver C. Barksdale & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 38 quarters since.
- Weaver C. Barksdale & Associates's Johnson & Johnson position peaked at $1.67M in Q1 2023.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.